Currently out of the existing stock ratings of Roanna Ruiz, 37 are a BUY (62.71%), 22 are a HOLD (37.29%).

Roanna Ruiz

Work Performance Price Targets & Ratings Chart

Analyst Roanna Ruiz, currently employed at LEERINK, carries an average stock price target met ratio of 50.64% that have a potential upside of 40.79% achieved within 259 days.

Roanna Ruiz’s has documented 113 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SPRY, ARS Pharmaceuticals at 25-Jun-2026.

Wall Street Analyst Roanna Ruiz

Analyst best performing recommendations are on MYOV (MYOVANT SCIENCES LTD).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 11/9/2021. The price target of $92 was fulfilled within 1 day with a profit of $2.36 (2.5%) receiving and performance score of 25.01.

Average potential price target upside

of $77.4 (86.71%) on AMRN (AMARIN PLC).
of $23.33 (55.72%) on CYTK (CYTOKINETICS).
of $4.03 (26.04%) on MYOV (MYOVANT SCIENCES LTD).

VIR Vir Biotechnology AMRN Amarin PLC AQST Aquestive Therapeutics CRMD CorMedix CYTK Cytokinetics ENTA Enanta Pharmaceuticals MNKD MannKind Corp MYOV Myovant Sciences Ltd NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares PRDS Pardes Biosciences SPRY ARS Pharmaceuticals TRVI Trevi Therapeutics XERS Xeris Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Michelle Gilson (MORGAN STANLEY)